Aptus Pharma Ltd 52 Week High
Aptus Pharma Ltd
NSE: APPL
YEARHIGH
Key Highlights
- The 52 Week HIGH of Aptus Pharma Ltd is ₹ 277 as of 04 Mar 26 .
Company Fundamentals for Aptus Pharma Ltd
Market Price of Aptus Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 04 Mar 2026 | 261.25 |
| 02 Mar 2026 | 266.55 |
| 26 Feb 2026 | 271.95 |
| 25 Feb 2026 | 266.65 |
| 24 Feb 2026 | 261.45 |
| 23 Feb 2026 | 256.35 |
| 17 Feb 2026 | 251.35 |
| 16 Feb 2026 | 246.45 |
| 13 Feb 2026 | 241.65 |
| 12 Feb 2026 | 236.95 |
Asset Value vs Market Value of Aptus Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Aptus Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aptus Pharma Ltd
Historical Net Profit of Aptus Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aptus Pharma Ltd
Aptus Pharma Ltd News Hub
Shares of Aptus Pharma list in MT Group
The equity shares of Aptus Pharma (Scrip Code: 544529) are listed effective 30 September 2025 and ad
Read more
30 Sept 25
BSE SME Aptus Pharma cures listing-day jitters with premium opening
The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The
Read more
30 Sept 25
Aptus Pharma schedules board meeting
Aptus Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2025. Power
Read more
03 Nov 25
Aptus Pharma jumps 24% in six days
Shares of Aptus Pharma surged 23.89% in ten trading sessions from its recent closing low of Rs 169.5
Read more
08 Jan 26
